Upstate Medical University News
The Central New York Biotech Accelerator is one of 17 SUNY business incubators that help to advance innovation and drive economic development throughout NYS.
Unchecked, AD cases are expected to reach 16 million by 2050. SUNY researchers are hard at work probing the causes, developing treatments and creating a cure.
Environmental influences on health care range from weather pattern changes to the increasing use of nanomaterials in consumer products.
Upstate professor William Kerr is exploring how manipulating a gene could significantly improve blood cell recovery following chemotherapy.
SUNY researchers are at the leading edge of rapid developments in materials, devices, systems, manufacturing processes and the engineering of computers.
Working with global partners, researchers on SUNY’s campuses are making a difference in the lives of people around the world.
SUNY Upstate researcher Frank Middleton says a biomarker found in saliva may lead to earlier diagnosis of autism.
SUNY ZAP! helps SUNY’s scientists and engineers take research from the lab to the marketplace.
SUNY is taking a leadership role to mitigate the causes of climate change and reduce vulnerability to the environmental challenges caused by a warming Earth.
Collegiality in the SUNY system leads to new lines of research and new approaches to antibiotic development.
Researchers across the SUNY campuses are attacking the problem of Alzheimer’s from every possible angle.
SUNY employing its talented faculty and leading-edge facilities to approach this public health crisis from several angles.
SUNY Upstate urologist looks to patient’s mouths for help repairing urethral strictures.
SUNY Technology Accelerator Fund investment advances promising therapy.
An Upstate Medical University professor of medicine investigates retrovirus and other causes of disease in humans.
The new set of cognitive tests will help doctors and clinicians properly diagnose and manage concussions.
SURF requires each fellow to think a project through from beginning to end, formulating a hypothesis and developing a theme.
The NSF-funded project will build on Anna Stewart Ibarra’s studies into the ecology of infectious diseases.
New technology that could help patients regrow blood cells after chemotherapy, radiation, or bone marrow transplants may also treat obesity.
Upstate was selected to partner in this effort because of its clinical trial center and expertise in dengue disease and human infection trials.
Findings may aid in the development of drugs to suppress tumors or provide more precision in the treatment of aggressive cancers.
Researchers are working to open our eyes to a new understanding of what drives myopia onset and progression, with a goal of uncovering new treatments.